RALPH V BOCCIA M.D.
Prescription History 1881663284
Internal Medicine - Hematology & Oncology in Bethesda, MD
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for RALPH V BOCCIA M.D., an active Hematology & Oncology specialist practicing in Bethesda, MD. Our medical registry currently tracks 24 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 694 documented patient claims. Among these therapy options, the most frequently utilized medication is Eliquis, which accounts for 84 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other MD PrescribersVs. MD Avg |
|---|---|---|---|
| EliquisApixaban | 84 | $805.71▼ below MD avg | ▲ More than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 84 Medicare prescriptions for Eliquis, about 1.3 times the volume of the typical Maryland prescriber of this medication (65). Medicare paid an average of $805.71 per fill, versus $880.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 117.4 30-Day Fills standardized to 30-day supplies 3,521 Days of Medication total across all patients in 2023 | |||
| RevlimidLenalidomide | 67 | $17,089.00▼ below MD avg | ▲ More than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 67 Medicare prescriptions for Revlimid, about 1.8 times the volume of the typical Maryland prescriber of this medication (38). Medicare paid an average of $17,089.00 per fill, versus $18,099.73 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 67 30-Day Fills standardized to 30-day supplies 1,876 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 57 | $12.58▼ below MD avg | ≈ Typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 57 Medicare prescriptions for Gabapentin, about 86% of the volume of the typical Maryland prescriber of this medication (66). Medicare paid an average of $12.58 per fill, versus $21.13 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 72 30-Day Fills standardized to 30-day supplies 2,160 Days of Medication total across all patients in 2023 | |||
| XareltoRivaroxaban | 51 | $1,194.60 | ▲ More than typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2023, this provider wrote 51 Medicare prescriptions for Xarelto, about 1.4 times the volume of the typical Maryland prescriber of this medication (37). Medicare paid an average of $1,194.60 per fill, versus $986.80 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 113 30-Day Fills standardized to 30-day supplies 3,390 Days of Medication total across all patients in 2023 | |||
| CalquenceAcalabrutinib Maleate | 51 | $15,822.90 | ▲ More than typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 51 Medicare prescriptions for Calquence, about 3.2 times the volume of the typical Maryland prescriber of this medication (16). Medicare paid an average of $15,822.90 per fill, versus $14,971.97 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 51 30-Day Fills standardized to 30-day supplies 1,530 Days of Medication total across all patients in 2023 | |||
| Dexamethasone | 50 | $21.71▼ below MD avg | ▲ More than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2023, this provider wrote 50 Medicare prescriptions for Dexamethasone, about 1.9 times the volume of the typical Maryland prescriber of this medication (26). Medicare paid an average of $21.71 per fill, versus $22.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 60.4 30-Day Fills standardized to 30-day supplies 1,639 Days of Medication total across all patients in 2023 | |||
| JakafiRuxolitinib Phosphate | 44 | $17,113.10▼ below MD avg | ▲ More than typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 44 Medicare prescriptions for Jakafi, about 2.2 times the volume of the typical Maryland prescriber of this medication (20). Medicare paid an average of $17,113.10 per fill, versus $17,580.89 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 44 30-Day Fills standardized to 30-day supplies 1,320 Days of Medication total across all patients in 2023 | |||
| Acyclovir | 30 | $14.34▼ below MD avg | ▲ More than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2023, this provider wrote 30 Medicare prescriptions for Acyclovir, about 1.5 times the volume of the typical Maryland prescriber of this medication (20). Medicare paid an average of $14.34 per fill, versus $29.27 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 48 30-Day Fills standardized to 30-day supplies 1,440 Days of Medication total across all patients in 2023 | |||
| Letrozole | 29 | $38.29 | ▼ Less than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2023, this provider wrote 29 Medicare prescriptions for Letrozole, about 63% of the volume of the typical Maryland prescriber of this medication (46). Medicare paid an average of $38.29 per fill, versus $28.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 84 30-Day Fills standardized to 30-day supplies 2,520 Days of Medication total across all patients in 2023 | |||
| BrukinsaZanubrutinib | 25 | $15,412.45 | ≈ Typical |
About Brukinsa: This medication is used to treat certain cancers (mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Zanubrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 25 Medicare prescriptions for Brukinsa, about the same volume as the typical Maryland prescriber of this medication (23). Medicare paid an average of $15,412.45 per fill, versus $13,099.89 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2023 | |||
| Hydroxyurea | 24 | $61.96 | ≈ Typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2023, this provider wrote 24 Medicare prescriptions for Hydroxyurea, about 89% of the volume of the typical Maryland prescriber of this medication (27). Medicare paid an average of $61.96 per fill, versus $38.18 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 58.1 30-Day Fills standardized to 30-day supplies 1,717 Days of Medication total across all patients in 2023 | |||
| Warfarin Sodium | 22 | $13.25▼ below MD avg | ▼ Less than typical |
About Warfarin Sodium: This medication is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and/or to prevent new clots from forming in your body. Show more ▾ Preventing harmful blood clots helps to reduce the risk of a stroke or heart attack. Conditions that increase your risk of developing blood clots include a certain type of irregular heart rhythm (atrial fibrillation), heart valve replacement, recent heart attack, and certain surgeries (such as hip/knee replacement). Warfarin is commonly called a blood thinner, but the more correct term is anticoagulant. It helps to keep blood flowing smoothly in your body by decreasing the amount of certain substances (clotting proteins) in your blood. An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. In 2023, this provider wrote 22 Medicare prescriptions for Warfarin Sodium, about half the volume of the typical Maryland prescriber of this medication (42). Medicare paid an average of $13.25 per fill, versus $14.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 44 30-Day Fills standardized to 30-day supplies 1,320 Days of Medication total across all patients in 2023 | |||
| ErleadaApalutamide | 22 | $13,582.54▼ below MD avg | ≈ Typical |
About Erleada: Apalutamide is used to treat men with prostate cancer. Show more ▾ This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. In 2023, this provider wrote 22 Medicare prescriptions for Erleada, about 81% of the volume of the typical Maryland prescriber of this medication (27). Medicare paid an average of $13,582.54 per fill, versus $14,869.78 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2023 | |||
| Lenalidomide | 20 | $16,471.15 | ▼ Less than typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 20 Medicare prescriptions for Lenalidomide, about half the volume of the typical Maryland prescriber of this medication (35). Medicare paid an average of $16,471.15 per fill, versus $12,598.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 560 Days of Medication total across all patients in 2023 | |||
| Megestrol Acetate | 14 | $355.95 | ≈ Typical |
About Megestrol Acetate: Megestrol is used to treat loss of appetite and weight loss in people with AIDS. Show more ▾ Improving your appetite and gaining weight may help you feel better and be more active. Megestrol is similar to a natural substance made by the body called progesterone. Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) In 2023, this provider wrote 14 Medicare prescriptions for Megestrol Acetate, about 82% of the volume of the typical Maryland prescriber of this medication (17). Medicare paid an average of $355.95 per fill, versus $90.57 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2023 | |||
| Exemestane | 13 | $162.00▼ below MD avg | ▼ Less than typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. In 2023, this provider wrote 13 Medicare prescriptions for Exemestane, about half the volume of the typical Maryland prescriber of this medication (26). Medicare paid an average of $162.00 per fill, versus $278.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| IbrancePalbociclib | 13 | $16,428.70 | ▼ Less than typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 13 Medicare prescriptions for Ibrance, about half the volume of the typical Maryland prescriber of this medication (25). Medicare paid an average of $16,428.70 per fill, versus $14,356.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2023 | |||
| Potassium Chloride | 12 | $72.20 | ▼ Less than typical |
About Potassium Chloride: This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. Show more ▾ A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with water pills/diuretics. A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. In 2023, this provider wrote 12 Medicare prescriptions for Potassium Chloride, about a quarter of the volume of the typical Maryland prescriber of this medication (43). Medicare paid an average of $72.20 per fill, versus $32.18 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14.7 30-Day Fills standardized to 30-day supplies 423 Days of Medication total across all patients in 2023 | |||
| Atorvastatin Calcium | 11 | $3.07▼ below MD avg | ▼ Less than typical |
About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. In 2023, this provider wrote 11 Medicare prescriptions for Atorvastatin Calcium, about 7% of the volume of the typical Maryland prescriber of this medication (151). Medicare paid an average of $3.07 per fill, versus $15.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| PromactaEltrombopag Olamine | 11 | $8,221.93▼ below MD avg | ▼ Less than typical |
About Promacta: This medication is used to treat low platelet levels in people who have a certain blood disorder called chronic immune (idiopathic) thrombocytopenia purpura (ITP) or who have chronic hepatitis C. Show more ▾ It may also be used to treat people with a certain blood disorder (aplastic anemia). Platelets are a type of blood cell needed to form blood clots and prevent bleeding. Eltrombopag decreases your risk of bleeding by increasing the number of platelets. Eltrombopag acts like a certain natural substance (thrombopoietin) that causes the body to produce platelets. In 2023, this provider wrote 11 Medicare prescriptions for Promacta, about 73% of the volume of the typical Maryland prescriber of this medication (15). Medicare paid an average of $8,221.93 per fill, versus $12,509.88 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| TagrissoOsimertinib Mesylate | 11 | $17,232.67 | ▼ Less than typical |
About Tagrisso: This medication is used to treat lung cancer. Show more ▾ Osimertinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors. In 2023, this provider wrote 11 Medicare prescriptions for Tagrisso, about half the volume of the typical Maryland prescriber of this medication (22). Medicare paid an average of $17,232.67 per fill, versus $16,919.42 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| TasignaNilotinib Hcl | 11 | $19,797.31 | ▼ Less than typical |
About Tasigna: Nilotinib is used to treat a certain type of blood cancer (chronic myelogenous leukemia-CML). Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 11 Medicare prescriptions for Tasigna, about 69% of the volume of the typical Maryland prescriber of this medication (16). Medicare paid an average of $19,797.31 per fill, versus $16,194.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2023 | |||
| DopteletAvatrombopag Maleate | 11 | $6,738.51 | – No State Data |
About Doptelet: This medication is used by people with chronic liver disease and a certain blood disorder (low platelet count) who are scheduled to have a medical or dental procedure. Show more ▾ Having a low platelet count increases the risk of too much bleeding during certain procedures. This medication increases the production of platelets by your body to help prevent too much bleeding from the procedure. Avatrombopag is also used to treat people with a certain blood disorder known as chronic immune thrombocytopenia-ITP. This is a condition where the amount of platelets in the blood is lower than normal. ITP can lead to serious bleeding problems. This medication increases the production of platelets by your body to help prevent too much bleeding from ITP. In 2023, this provider wrote 11 Medicare prescriptions for Doptelet. Medicare paid an average of $6,738.51 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $6,738.51 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11.6 30-Day Fills standardized to 30-day supplies 317 Days of Medication total across all patients in 2023 | |||
| LynparzaOlaparib | 11 | $15,404.45 | ≈ Typical |
About Lynparza: This medication is used to treat certain cancers (such as breast, ovarian, fallopian tube, pancreatic, peritoneal cancer, prostate). Show more ▾ Olaparib works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 11 Medicare prescriptions for Lynparza, about 79% of the volume of the typical Maryland prescriber of this medication (14). Medicare paid an average of $15,404.45 per fill, versus $14,022.44 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for RALPH V BOCCIA M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Bethesda, MD practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MD prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
